Weighing the benefits

The SIPP industry has long been salivating at the prospect of getting its hands on the £100 billion or so of protected rights assets which have been languishing for 20 years in under-performing life company funds. Finally, on 1 October last year, they got what they wanted - or did they? The timing was, to say the least, unfortunate as the following six months have been among the most turbulent in stock market history. Perhaps those boring old life company funds were not so under-performing after all. Against this background, what are the pros and cons of transferring protected rights into a...